EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica



Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica



Journal of Experimental Medicine 186(9): 1557-1565



A panel of monoclonal antibodies was raised from mice immunized with a membrane preparation from Entamoeba histolytica, the pathogenic species causing invasive amebiasis in humans. Antibody EH5 gave a polydisperse band in immunoblots from membrane preparations from different E. histolytica strains, and a much weaker signal from two strains of the nonpathogenic species Entamoeba dispar. Although the exact chemical structure of the EH5 antigen is not yet known, the ability of the antigen to be metabolically radiolabeled with (32P)phosphate or (3H)glucose, its sensitivity to digestion by mild acid and phosphatidylinositol-specific phospholipase C, and its specific extraction from E. histolytica trophozoites by a method used to prepare lipophosphoglycans from Leishmania showed that it could be classified as an amebal lipophosphoglycan. Confocal immunofluorescence and immunogold labeling of trophozoites localized the antigen on the outer face of the plasma membrane and on the inner face of internal vesicle membranes. Antibody EH5 strongly agglutinated amebas in a similar way to concanavalin A (Con A), and Con A bound to immunoaffinity-purified EH5 antigen. Therefore, surface lipophosphoglycans may play an important role in the preferential agglutination of pathogenic amebas by Con A. The protective ability of antibody EH5 was tested in a passive immunization experiment in a severe combined immunodeficient (SCID) mouse model. Intrahepatic challenge of animals after administration of an isotype-matched control antibody or without treatment led to the development of a liver abscess in all cases, whereas 11 out of 12 animals immunized with the EH5 antibody developed no liver abscess. Our results demonstrate the importance and, for the first time, the protective capacity of glycan antigens on the surface of the amebas.

(PDF 0-2 workdays service: $29.90)

Accession: 003245390

Download citation: RISBibTeXText

PMID: 9348313



Related references

Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis. Journal of Experimental Medicine 185(10): 1793-1801, 1997

Entamoeba histolytica: fecal antigen capture immunoassay for the diagnosis of enteric amebiasis by a monoclonal antibody. Revista do Instituto de Medicina Tropical de Sao Paulo 38(1): 39-44, 1996

Monoclonal antibody-based ELISA for the detection of circulating Entamoeba histolytica antigen in hepatic amebiasis in hamsters (Mesocricetus auratus). Southeast Asian Journal of Tropical Medicine and Public Health 27(4): 760-764, 1996

Monoclonal antibody against surface antigen of Entamoeba histolytica HM1. Bulletin Postgraduate Institute of Medical Education and Research, Chandigarh 29(1): 25-31, 1995

Inhibition of adhesion by monoclonal antibody to 66 kDa surface antigen of Entamoeba histolytica. Archives of Medical Research 23(2): 235-237, 1992

Recognition of Entamoeba histolytica lipophosphoglycan by a strain-specific monoclonal antibody and human immune sera. Molecular and Biochemical Parasitology 56(2): 279-287, 1992

Entamoeba histolytica: identification of a major surface antigen in liver abscess pus using a monoclonal antibody. Transactions of the Royal Society of Tropical Medicine and Hygiene 87(4): 489, 1993

Inhibition of target cell adhesion by monoclonal antibody to the 66 kD surface antigen of Entamoeba histolytica. Infection 20(5): 279-282, 1992

Protection of hamsters from amebic liver abscess formation by a monoclonal antibody to a 150-kDa surface lectin of Entamoeba histolytica. Parasitology Research 85(1): 78-80, 1999

A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica. Infection and Immunity 70(10): 5873-5876, 2002

Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica antigen-based ELISA. Archives of Medical Research 23(2): 285-288, 1992

Bacterial expression of a neutralizing mouse monoclonal antibody Fab fragment to a 150-kilodalton surface antigen of Entamoeba histolytica. American Journal of Tropical Medicine and Hygiene 60(1): 35-40, 1999

Induction of immunity to amebiasis in subhuman primates by lysosomal antigen of Entamoeba histolytica. IV. Cytopathogenic effect of monkey serum on trophozoites of Entamoeba histolytica. Archivos de Investigacion Medica 11(1 Suppl): 257-262, 1980

Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 32(4): 964-970, 1994